Financial Select Sector SPDR (XLF) 24.11 $XLF U.S.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Financial Select Sector SPDR (XLF) 24.11 $XLF

U.S. Stocks Have Potential, but International Equities Are More Attractive
at The Street - 1 hr 33 mins ago
David Joy, chief market strategist at Ameriprise Financial, says U.S. stocks could climb in the second half of the year, but he likes European and Japanese equities.
EWI: 14.80 (-0.18), EWG: 29.84 (-0.52), EWQ: 25.98 (-0.40), EWP: 34.78 (-0.25), DXJS: 33.97 (-0.18), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), HEWG: 28.54 (-0.35), DXJ: 55.12 (-0.97), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), EWU: 18.01 (-0.31), DIA: 177.58 (-1.81), EWGS: 39.41 (-0.62), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), XLE: 77.58 (-0.46)

Bank Of America - Will Q1 EPS Bring Risk Or Reward?
Markos Kaminis - at Seeking Alpha - Tue Mar 31, 2:27PM CDT

SPY: 206.43 (-1.82), GS: 187.97 (-3.05), JPM: 60.58 (-0.38), USB: 43.67 (-0.12), C: 51.52 (-0.12), BAC: 15.39 (-0.13), WFC: 54.40 (-0.37), XLF: 24.11 (-0.17), MS: 35.69 (-0.62)

Worst Revenue And Earnings Declines Since Crisis Year 2009
Wolf Richter - at Seeking Alpha - Mon Mar 30, 8:16AM CDT
Stocks have soared. But despite maxed-out financial engineering and ceaseless Wall-Street hype, the first half is shaping up to be tough. Week after week, corporations and analysts have been whittling down their estimates. By now, revenues of the...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

The Incredible Shrinking Earnings Forecast
Eric Parnell, CFA - at Seeking Alpha - Sun Mar 29, 1:18AM CDT

XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), XOM: 85.00 (-0.63), XLI: 55.77 (-0.56), XLF: 24.11 (-0.17), CVX: 104.98 (-1.92), XLE: 77.58 (-0.46)

Business Lending At Commercial Banks Has Increased
John M. Mason - at Seeking Alpha - Fri Mar 27, 5:34PM CDT

FAS: 122.22 (-2.00), FAZ: 12.38 (+0.21), XLF: 24.11 (-0.17)

Which Is Better: Cap-Weighting Or Equal-Weighting?
John Dowdee - at Seeking Alpha - Fri Mar 27, 3:56PM CDT

RYH: 155.22 (-2.05), RTM: 85.63 (-0.82), XLB: 48.78 (-0.49), RSP: 81.05 (-0.56), XLY: 75.35 (-0.33), XLU: 44.43 (+0.01), RYT: 91.90 (-0.69), XLV: 72.50 (-1.28), RYU: 74.25 (-0.30), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), RGI: 89.89 (-0.50), XLK: 41.44 (-0.43), RCD: 91.64 (-0.03), XLI: 55.77 (-0.56), RHS: 107.94 (-0.87), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), XLE: 77.58 (-0.46)

Market Trend Analysis By Comparing Equal Weight To Market Weight Indexes
Richard Shaw - Seeking Alpha - Fri Mar 27, 10:20AM CDT
As a generality, a healthy stock market up trend has broad participation in the trend by a large or increasing portion of its constituents; and conversely an unhealthy market has a low or declining portion of it constituents participating in an up...
RYH: 155.22 (-2.05), XLB: 48.78 (-0.49), RTM: 85.63 (-0.82), RSP: 81.05 (-0.56), EWRS: 46.25 (+0.14), XLY: 75.35 (-0.33), QQEW: 43.80 (-0.43), XLU: 44.43 (+0.01), RYT: 91.90 (-0.69), XLV: 72.50 (-1.28), RYU: 74.25 (-0.30), IWB: 115.85 (-1.01), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), RGI: 89.89 (-0.50), XLK: 41.44 (-0.43), RCD: 91.64 (-0.03), XLI: 55.77 (-0.56), RHS: 107.94 (-0.87), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), XLE: 77.58 (-0.46), EWRI: 52.09 (-0.34)

Pleasant surprise may in store in bank earnings in April
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 3:37PM CDT

FINZ: 22.12 (+1.24), UYG: 145.21 (-1.94), SEF: 17.58 (+0.14), KCE: 50.31 (-0.21), VFH: 49.28 (-0.29), KBWC: 56.15 (unch), FINU: 83.86 (-0.79), C: 51.52 (-0.12), BAC: 15.39 (-0.13), IYG: 89.49 (-0.34), IYF: 89.05 (-0.48), MS: 35.69 (-0.62), GS: 187.97 (-3.05), JPM: 60.58 (-0.38), FNCL: 28.76 (-0.15), FXO: 23.62 (-0.09), RWW: 48.81 (-0.24), IAI: 42.84 (-0.27), FAS: 122.22 (-2.00), XLF: 24.11 (-0.17), FAZ: 12.38 (+0.21), RYF: 44.56 (-0.18)

My 2015 Select Sector SPDR ETFs Algorithmic Forecast And Allocation
I Know First Research - at Seeking Alpha - Thu Mar 26, 11:52AM CDT

XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), IPS: 40.21 (-0.64), XLK: 41.44 (-0.43), IPW: 19.34 (-0.22), XLF: 24.11 (-0.17), IPK: 33.57 (-0.39), IRY: 51.69 (-0.84), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

OCI Study: Understanding Bank Performance, Risk Through 'Forgotten' Income Statement
CFA Institute Contributors - Seeking Alpha - Wed Mar 25, 1:44PM CDT
By Vincent Papa, PhD, CFA With banks' earnings season in full swing and the looming threat of rising interest rates, a pertinent question remains: How effectively are investors monitoring the performance and risk profile of banks? At the...
FINZ: 22.12 (+1.24), UYG: 145.21 (-1.94), SEF: 17.58 (+0.14), VFH: 49.28 (-0.29), FINU: 83.86 (-0.79), IYG: 89.49 (-0.34), IYF: 89.05 (-0.48), FXO: 23.62 (-0.09), FNCL: 28.76 (-0.15), RWW: 48.81 (-0.24), FAS: 122.22 (-2.00), XLF: 24.11 (-0.17), FAZ: 12.38 (+0.21), RYF: 44.56 (-0.18)

Selloff in Biotech Continues; Should You Worry About Tech Sector?
at The Street - Wed Mar 25, 1:28PM CDT
The CNBC ‘Fast Money Halftime’ trading panel looks at biotech stocks, the broader market and the tech sector.
BIIB: 422.24 (-9.38), TROW: 80.98 (-0.76), BLK: 365.84 (-2.26), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), FNF: 36.76 (+0.17), IBB: 343.43 (-7.89), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), CELG: 115.28 (-4.74), VLO: 63.62 (-0.14), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), GILD: 98.13 (-2.56), DIA: 177.58 (-1.81), XLK: 41.44 (-0.43), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), AAPL: 124.43 (-1.94), REGN: 451.48 (-8.30)

The Future's Not Over Yet: A Retrospective On Peter Thiel's 2011 Predictions
Noise Dampener - at Seeking Alpha - Wed Mar 25, 1:28AM CDT
Peter Thiel is unique among Silicon Valley gurus in terms of his entrepreneurial success, as well as his libertarian political leanings. Part of his motivation for co-founding PayPal was to protect people in developing countries from the "fast...
XTN: 106.31 (-0.63), VFH: 49.28 (-0.29), XLF: 24.11 (-0.17), IYT: 156.62 (-0.84), VHT: 135.52 (-1.73), XLV: 72.50 (-1.28)

Visa, Wells Fargo Two of Fund Manager's Top Financial Picks
at The Street - Tue Mar 24, 3:35PM CDT
Ryan Kelley, portfolio manager for the Hennessy Large-Cap Financial Fund, breaks down the bullish catalysts for Wells Fargo, Visa and BankUnited.
V: 65.41 (-0.25), AXP: 78.12 (+0.07), WFC: 54.40 (-0.37), XLF: 24.11 (-0.17), BKU: 32.74 (-0.30)

Look for Well-Run Companies With Promising Catalysts Says Fidelity Manager
at The Street - Tue Mar 24, 2:29PM CDT
The CNBC 'Fast Money Halftime' trading panel tunes into what Will Danoff, portfolio manager of the $120 billion Fidelity Contrafund, has to say when it comes to picking stocks.
SOCL: 19.33 (-0.06), BIIB: 422.24 (-9.38), FB: 82.21 (-0.98), WFC: 54.40 (-0.37), KORS: 65.75 (-0.51), TLT: 130.69 (+0.28), GOOG: 548.00 (-4.03), XRT: 101.04 (-0.54), LULU: 64.02 (-0.81), WHR: 202.06 (+1.02), FSLR: 59.79 (-0.90), SPY: 206.43 (-1.82), LB: 94.29 (+0.09), QQQ: 105.60 (-1.13), LNKD: 249.86 (-5.33), IBM: 160.50 (-2.17), DIA: 177.58 (-1.81), ITB: 28.23 (-0.03), GOOGL: 554.70 (-6.44), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), TWTR: 50.08 (+0.19), AAPL: 124.43 (-1.94)

Stress Tests Are Imperfect: Global Data Indicates GFC-2 Is Imminent
Emily Muhleman, CFA - Seeking Alpha - Tue Mar 24, 12:35PM CDT
This WSJ article , "Beware the Silence of the Banks," does not describe what this post is about. In fact I disagree with the argument therein. I'd encourage readers to look to the last few paragraphs below regarding the message I'm trying...
UYG: 145.21 (-1.94), KBE: 33.51 (-0.09), QABA: 36.60 (-0.15), KRE: 40.83 (-0.16), FXO: 23.62 (-0.09), FNCL: 28.76 (-0.15), KIE: 67.09 (-0.34), FAS: 122.22 (-2.00), FAZ: 12.38 (+0.21), XLF: 24.11 (-0.17), RYF: 44.56 (-0.18), FINZ: 22.12 (+1.24), SEF: 17.58 (+0.14), VFH: 49.28 (-0.29), KCE: 50.31 (-0.21), KRS: 25.92 (-0.24), KBWB: 37.08 (-0.14), KBWC: 56.15 (unch), FINU: 83.86 (-0.79), KRU: 92.82 (-0.95), IYG: 89.49 (-0.34), IYF: 89.05 (-0.48), KBWI: 69.19 (-0.21), IAK: 49.49 (-0.16), KBWR: 40.05 (-0.25), IAI: 42.84 (-0.27), RWW: 48.81 (-0.24), KBWP: 43.82 (-0.35), PFI: 31.97 (-0.02), IAT: 34.87 (-0.10), PSCF: 41.69 (-0.43)

Groudhog Day for insurers and banks
Seeking Alpha - at Seeking Alpha - Tue Mar 24, 7:05AM CDT

FINZ: 22.12 (+1.24), UYG: 145.21 (-1.94), SEF: 17.58 (+0.14), VFH: 49.28 (-0.29), FINU: 83.86 (-0.79), MET: 50.55 (-0.38), IYG: 89.49 (-0.34), IYF: 89.05 (-0.48), KBWI: 69.19 (-0.21), IAK: 49.49 (-0.16), FNCL: 28.76 (-0.15), FXO: 23.62 (-0.09), RWW: 48.81 (-0.24), KBWP: 43.82 (-0.35), FAS: 122.22 (-2.00), KIE: 67.09 (-0.34), XLF: 24.11 (-0.17), FAZ: 12.38 (+0.21), RYF: 44.56 (-0.18)

Fed's Fischer Says 2015 Rate Hike Wouldn't Be Followed by Regular Increases
at The Street - Mon Mar 23, 2:01PM CDT
CNBC 'Fast Money Halftime' traders dissect what a rate hike would mean for U.S. stocks and learn what a contrarian fund manager is buying.
F: 16.14 (-0.02), VXX: 25.63 (+0.67), TM: 139.89 (-2.66), UUP: 25.90 (+0.04), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), UAL: 67.25 (-0.94), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), JOE: 18.56 (+0.38), DIA: 177.58 (-1.81), ETFC: 28.55 (+0.31), FXE: 105.71 (-0.61), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), TWTR: 50.08 (+0.19), AMTD: 37.26 (+0.04), SCHW: 30.44 (+0.08)

The Fed Trade That's Money In The Bank
Eric Parnell, CFA - at Seeking Alpha - Fri Mar 20, 1:49PM CDT

KRE: 40.83 (-0.16), SPY: 206.43 (-1.82), USB: 43.67 (-0.12), GLD: 113.66 (-0.09), BAC: 15.39 (-0.13), PNC: 93.24 (-0.61), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), VNQ: 84.31 (-0.75), TLT: 130.69 (+0.28)

Financial Select Sector SPDR announces quarterly distribution of $0.091
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 1:19PM CDT

XLF: 24.11 (-0.17)

WSJ: Banks struggling to unload energy loans
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 6:50AM CDT

FINZ: 22.12 (+1.24), UYG: 145.21 (-1.94), SEF: 17.58 (+0.14), KCE: 50.31 (-0.21), VFH: 49.28 (-0.29), KBWC: 56.15 (unch), FINU: 83.86 (-0.79), C: 51.52 (-0.12), UBS: 18.77 (-0.39), IYG: 89.49 (-0.34), IYF: 89.05 (-0.48), GS: 187.97 (-3.05), FNCL: 28.76 (-0.15), FXO: 23.62 (-0.09), RWW: 48.81 (-0.24), IAI: 42.84 (-0.27), FAS: 122.22 (-2.00), XLF: 24.11 (-0.17), FAZ: 12.38 (+0.21), RYF: 44.56 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading